Two Sigma Advisers’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SM
Two Sigma Advisers's MTRI Position: Q3 2022 in Review
Two Sigma Advisers sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2022, closing a stake of 10 shares — an estimated $23K sold.
Two Sigma Advisers first reported a position in MTRI in Q4 2021 and held it in 3 quarters. The position peaked at $270K in Q4 2021. 7 funds tracked by Wall St. Rank hold MTRI as of Q3 2022.
- Two Sigma Advisers reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Two Sigma Advisers sold 10 Mentari Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $23K.
- Two Sigma Advisers first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
- Two Sigma Advisers's Mentari Therapeutics, Inc. Common Stock position peaked at $270K in Q4 2021.
- 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.